(Q51480924)
Statements
Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice. (English)
1 reference
Mitsuo Tanimoto
1 reference
Tomohito Gohda
1 reference
Shigeru Kaneko
1 reference
Shinji Hagiwara
1 reference
Maki Murakoshi
1 reference
Tatsuya Aoki
1 reference
Kaori Yamada
1 reference
Takamichi Ito
1 reference
Masakazu Matsumoto
1 reference
Satoshi Horikoshi
1 reference
Yasuhiko Tomino
1 reference
1 February 2007
1 reference
56
1 reference
2
1 reference
160-167
1 reference